| Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis (NCT07686081) | Vanda Pharmaceuticals | 2026-09-01 |
| A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use (NCT07446439) | Vanda Pharmaceuticals | 2026-03-27 |
| Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis (NCT07362017) | Vanda Pharmaceuticals | 2026-02-17 |
| An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye (NCT07179055) | Vanda Pharmaceuticals | 2025-10-01 |
| Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder (NCT07221578) | Vanda Pharmaceuticals | 2025-09-22 |
| Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension (NCT07090161) | Vanda Pharmaceuticals | 2025-09-15 |
| Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient (NCT07223632) | Vanda Pharmaceuticals | 2025-05-13 |
| Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis (NCT07065773) | Vanda Pharmaceuticals | 2025-05-05 |
| Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia (NCT06953869) | Vanda Pharmaceuticals | 2025-04-21 |
| Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder (NCT06830044) | Vanda Pharmaceuticals | 2025-03-03 |
| A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use (NCT06804603) | Vanda Pharmaceuticals | 2025-02-25 |
| Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant (NCT06701396) | Vanda Pharmaceuticals | 2024-10-08 |
| Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions (NCT06494397) | Vanda Pharmaceuticals | 2024-07-11 |
| A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye (NCT06296966) | Vanda Pharmaceuticals | 2024-02-29 |
| Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis (NCT06836557) | Vanda Pharmaceuticals | 2024-01-09 |
| Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness (NCT05903924) | Vanda Pharmaceuticals | 2023-09-09 |
| Safety and Tolerability of Open-Labeled Iloperidone in Adolescents (NCT05648591) | Vanda Pharmaceuticals | 2023-05-24 |
| Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness (NCT06138613) | Vanda Pharmaceuticals | 2023-02-27 |
| Food Effect Study of VHX-896 in Healthy Volunteers (NCT06803290) | Vanda Pharmaceuticals | 2022-06-21 |
| A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis (NCT05344365) | Vanda Pharmaceuticals | 2022-06-01 |
| Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers (NCT05572281) | Vanda Pharmaceuticals | 2022-05-18 |
| Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP (NCT05366855) | Vanda Pharmaceuticals | 2022-04-21 |
| Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP (NCT05352893) | Vanda Pharmaceuticals | 2022-04-14 |
| Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness (NCT04327661) | Vanda Pharmaceuticals | 2021-11-15 |
| Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances (NCT05361707) | Vanda Pharmaceuticals | 2021-07-28 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa (NCT04856930) | Vanda Pharmaceuticals | 2021-07-07 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris (NCT04856917) | Vanda Pharmaceuticals | 2021-05-15 |
| Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder (NCT04819776) | Vanda Pharmaceuticals | 2021-03-22 |
| Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety (NCT04800237) | Vanda Pharmaceuticals | 2021-02-23 |
| Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers (NCT04849559) | Vanda Pharmaceuticals | 2021-02-01 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis (NCT04697056) | Vanda Pharmaceuticals | 2021-01-25 |
| A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia (NCT04712734) | Vanda Pharmaceuticals | 2021-01-13 |
| Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) (NCT04652882) | Vanda Pharmaceuticals | 2020-12-09 |
| WGS Analysis of COVID-19 Positive Patients (NCT04353401) | Vanda Pharmaceuticals | 2020-08-03 |
| ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection (NCT04326426) | Vanda Pharmaceuticals | 2020-04-13 |
| Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) (NCT04140695) | Vanda Pharmaceuticals | 2019-10-21 |
| Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia (NCT04127058) | Vanda Pharmaceuticals | 2019-10-07 |
| Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis (NCT04028492) | Vanda Pharmaceuticals | 2019-08-20 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis (NCT03633396) | Vanda Pharmaceuticals | 2019-05-20 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis (NCT03619902) | Vanda Pharmaceuticals | 2019-01-30 |
| Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness (NCT03772340) | Vanda Pharmaceuticals | 2018-12-20 |
| Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies (NCT03838926) | Vanda Pharmaceuticals | 2018-09-27 |
| Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects (NCT06323655) | Vanda Pharmaceuticals | 2018-07-19 |
| Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) (NCT03568331) | Vanda Pharmaceuticals | 2018-07-09 |